Investigators examined how genetic factors associated with cardiovascular and non-cardiovascular diseases may have an effect on reported comorbid conditions.
Your search for comorbidities returned 17 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Further studies are needed to understand the effect of smoking cessation on outcomes in patients undergoing transcatheter aortic valve replacement.
The risk of sudden cardiac death was present across all strata of left ventricular ejection fraction and was related to the use of cocaine, lower use of beta-blockers, lower CD4, and nonsuppressed viral load.
Early mortality after atrial fibrillation ablation may be predicted by the occurrence of heart failure, procedural complications, as well as low hospital AF ablation.
Significant improvements to the management of metabolic syndrome after liver transplantation must be made to reduce the risk for CV events and mortality.
US and European guidelines for the diagnosis and management of syncope are similar.
Glucose-lowering medications and high-intensity statins are not being used sufficiently among high-risk individuals with atherosclerotic cardiovascular disease and diabetes.
Researchers assessed the association between long-term usage of PPIs and the adverse events of dementia, pneumonia, intestinal infections, and chronic kidney disease.
Investigators sought to identify risk factors and develop a predictive risk score for new pacemaker implantation after transcatheter aortic valve replacement.
Investigators assessed national trends on the incidence and geographical distribution of drug abuse with infective endocarditis and contributing factors for outcome in this patient population.